HCW BIOLOGICS INC (HCWB)

NASDAQHealth CareBiotechnologySnapshot 2026-09-04

$2.94+2.44%

Close 2026-09-04 · 1-day change

QuarterlyIQ Insights · HCWB

Financials

Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.

Income Statement

Period

View

Order

Figures in millions of None, except per-share and ratios.

	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Revenues
Revenues	6.7	0.1	2.6	2.8	6.7	0.0	4.1
Total Revenues	—	—	—	—	—	—	4.1
Cost of Revenues	0.3	0.0	1.6	2.3	4.1	0.0	—
Gross Profit	6.4	0.0	1.0	0.6	2.6	0.0	—
Operating Expenses & Income
R&D Expenses	5.2	5.4	6.4	7.7	9.3	8.2	7.3
Other Operating Expenses, Total	0.0	0.1	0.1	1.0	0.3	—	—
Operating Income	(7.7)	(13.2)	(29.5)	(25.7)	(15.1)	(13.4)	(5.8)
Earnings from Continuing Operations
Interest Expense	0.6	0.8	0.6	0.3	0.1	0.0	—
EBT, Incl. Unusual Items	—	(8.0)	(30.0)	(25.0)	(14.9)	(12.9)	(5.8)
Income Tax Expense	—	—	—	0.0	0.0	0.0	0.0
Net Income
Net Income	(5.6)	(8.0)	(30.0)	(25.0)	(14.9)	(12.9)	(5.8)
Per Share
Basic EPS	(4.20)	(10.63)	(0.77)	(0.70)	(0.42)	(0.69)	—
Diluted EPS	(4.20)	(10.63)	(0.77)	(0.70)	(0.42)	(0.69)	—
Revenue per Share	5.02	—	—	—	—	—	—
Basic Weighted Avg Shares	1.3	2.1	38.8	35.9	35.8	18.8	—
Diluted Weighted Avg Shares	1.3	2.1	38.8	35.9	35.8	18.8	—
Supplemental
EBITDA	—	(12.1)	(28.3)	(24.6)	(14.4)	(12.8)	(5.3)
EBIT	(7.7)	(13.2)	(29.5)	(25.7)	(15.1)	(13.4)	(5.8)
Effective Tax Rate	—	—	—	0.0%	0.0%	0.0%	0.0%

Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.